1.       Johnson SB, Eng TY, Giaccone G, Thomas CR Jr. Thymoma: update for the new millennium. Oncologist. 2001;6:239-46.

2.       Thomas CR, Wright CD, Loehrer PJ. Thymoma: state of the art. J Clin Oncol. 1999;17:2280-9.

3.       Singhal S, Shrager JB, Rosenthal DI, et al. Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg. 2003;76:1635-41.

4.       Ogawa K, Uno T, Toita T, Onishi H, et al. Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients. Cancer. 2002;94:1405-13.

5.       Harmer C, Bidmead M, Shepherd S, et al. Radiotherapy planning techniques for thyroid cancer. Br J Radiol. 1998;71:1069-75.

6.       Nutting CM, Convery DJ, Cosgrove VP, et al. Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. Radiother Oncol. 2001;60:173-80.

7.       Kiess AP, Agrawal N, Brierley JD, Duvvuri U, Ferris RL, Genden E, Wong RJ, Tuttle RM, Lee NY, Randolph GW. External-beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society. Head Neck. 2016 Apr;38(4):493-8. doi: 10.1002/hed.24357. Epub 2015 Dec 30. PMID: 26716601; PMCID: PMC4975923.

8.       Xue F, Li D, Hu C, Wang Z, He X, Wu Y. Application of intensity-modulated radiotherapy in unresectable poorly differentiated thyroid carcinoma. Oncotarget. 2017 Feb 28;8(9):15934-15942. doi: 10.18632/oncotarget.12785. PMID: 27776342; PMCID: PMC5362535.

9.       Beckham TH, Romesser PB, Groen AH, Sabol C, Shaha AR, Sabra M, Brinkman T, Spielsinger D, McBride S, Tsai CJ, Riaz N, Tuttle RM, Fagin JA, Sherman EJ, Wong RJ, Lee NY. Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual Disease. Thyroid. 2018 Sep;28(9):1180-1189. doi: 10.1089/thy.2018.0214. PMID: 30105947; PMCID: PMC6154443.

10.    Posner MD, Quivey JM, Akazawa PF, et al. Dose optimization for the treatment of anaplastic thyroid carcinoma: a comparison of treatment planning techniques. Int J Radiat Oncol Biol Phys. 2000;48:475-83.

11.    He X, Li D, Hu C, Wang Z, Ying H, Wu Y. Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma. BMC Cancer. 2014 Apr 2;14:235. doi: 10.1186/1471-2407-14-235. PMID: 24690325; PMCID: PMC3976675.

12.    Fan D, Ma J, Bell AC, Groen AH, Olsen KS, Lok BH, Leeman JE, Anderson E, Riaz N, McBride S, Ganly I, Shaha AR, Sherman EJ, Tsai CJ, Kang JJ, Lee NY. Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer. Cancer. 2020 Jan 15;126(2):444-452. doi: 10.1002/cncr.32548. Epub 2019 Oct 8. PMID: 31593317; PMCID: PMC7302673.